bioRxivImmunologyPreprint
Neuroprotective tissue adaptation induced by IL-12 attenuates CNS inflammation
M. Andreadou, F. Ingelfinger, D. De Feo, E. Friebel, S. Tuzlak, T. M. L. Cramer, B. Schreiner, P. Eede, S. Schneeberger, M. Geesdorf, F. Ridder, C. A. Welsh, D. Kirschenbaum, S. K. Tyagarajan, M. Greter, F. L. Heppner, S. Mundt, B. Becher
Abstract
IL-12 is a well-established driver of type 1 immune responses. Paradoxically, in several autoimmune conditions including neuroinflammation, IL-12 reduces pathology and exhibits regulatory properties. Yet, the mechanism and the involved cellular players behind this immune regulation remain elusive. To identify the IL-12-responsive elements which prevent immunopathology, we generated mouse models lacking a functional IL-12 receptor either in all cells or in specific populations within the immune or central nervous system (CNS) compartments, and induced experimental autoimmune encephalomyelitis (EAE), which models human Multiple Sclerosis (MS). This revealed that the CNS tissue-protective features of IL-12 are mediated by cells of the neuroectoderm, and not immune cells. Importantly, sections of brain from patients with MS show comparable patterns of expression, indicating parallel mechanisms in humans. By combining spectral flow cytometry, bulk and single-nucleus RNA sequencing, we uncovered an IL-12-induced neuroprotective adaption of the neuroectoderm critically involved in maintaining CNS tissue integrity during inflammation.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
D. Hwang, L. L. W. Ishiwaka, … B. Ciric·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 30, 2022
- Increased activity of IRE1 improves the clinical presentation of EAE
Valerie C. Bracchi-Ricard, Kayla Nguyen, … Yair Argon·The FASEB JournalPeer-reviewed·Nov 20, 2023
- The innate cytokine IL-18 inhibits CNS autoimmunity through preferential activation of protective CD8 T-cells
Jeremy A. Morrissette, Vinh Dang, … Scott Canna·bioRxiv·Jan 28, 2026
- Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway
M. E. Deerhake, K. Danzaki, … M. L. Shinohara·bioRxiv·May 6, 2020
- Targeting interferon-{lambda} signaling promotes recovery from central nervous system autoimmunity
S. Manivasagam, J. L. Williams, … R. S. Klein·bioRxiv·Aug 17, 2021
- The neuroinflammatory interleukin-12 signaling pathway drives Alzheimer's disease-like pathology by perturbing oligodendrocyte survival and neuronal homeostasis
Shirin Schneeberger, Seung Joon Kim, … Frank L. Heppner·bioRxiv·Apr 25, 2021